---
schema_version: "secwatch.filing_event.v1"
accession: "0001093557-26-000072"
form_type: "8-K"
ticker: "DXCM"
cik: "0001093557"
company_name: "DEXCOM INC"
filed_at: "2026-04-30T23:59:59+00:00"
generated_at: "2026-05-15T00:32:28.923545+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# Dexcom Q1 revenue $1.19B (+15% YoY), EPS $0.51; raises margin guidance

## Summary
- Q1 revenue $1.192B (+15% YoY); GAAP diluted EPS $0.51, non-GAAP $0.56.
- US revenue +11%, international +26% reported (+17% organic) YoY.
- GAAP operating margin 21.4% (+850 bps); non-GAAP 22.2% (+840 bps).
- FY2026 guidance: revenue $5.16-5.25B; non-GAAP op margin raised to 23-23.5%.
- Cash and marketable securities $2.42B; revolver undrawn.

## SEC filing metadata
- accession: 0001093557-26-000072
- form_type: 8-K
- ticker: DXCM
- cik: 0001093557
- company_name: DEXCOM INC
- filed_at: 2026-04-30T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000072/0001093557-26-000072-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000072/dxcm-20260430.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001093557-26-000072
- JSON: https://secwatch.observer/filing/0001093557-26-000072.json
- Plain text: https://secwatch.observer/filing/0001093557-26-000072.txt

## Key facts
- Earnings Releases
  DEXCOM INC reported quarter ended March 31, 2026 results: revenue $1.192 billion, net income $199.5 million, EPS $0.51.
  - Period: quarter ended March 31, 2026
  - Revenue: $1.192 billion
  - Net income: $199.5 million
  - EPS: $0.51
  - Result: reported results
  source text: (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended March 31, 2026. First Quarter 2026 Financial Highlights: • Revenue grew 15% year-over-year to $1.192 billion on a reported basis and 12% year-over-year on an organic 1 basis. • U.S. revenue grew 11% and international revenue grew 26% on a reported basis and 17% on an organic 1 basis,
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000072/0001093557-26-000072-index.htm
- Earnings Releases
  DEXCOM INC reported fiscal year 2026 results: revenue $5.16 - $5.25 billion. Guidance raised.
  - Period: fiscal year 2026
  - Revenue: $5.16 - $5.25 billion
  - Guidance: raised
  - Result: guidance update
  source text: Dexcom is raising fiscal year 2026 guidance for Non-GAAP Operating Margin and Adjusted EBITDA Margin, and reiterating guidance for Revenue and Non-GAAP Gross Profit Margin at the following levels: • Revenue of $5.16 - $5.25 billion (approximately 11-13% growth) • Non-GAAP Gross Profit Margin of approximately 63-64% • Non-GAAP Operating Margin of approximately 23-23.5% • Adjusted EBITDA Margin of approximately 31-31.5%
  evidence_url: https://www.sec.gov/Archives/edgar/data/1093557/000109355726000072/0001093557-26-000072-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.